| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.035 | 0.5 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.5 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.032 | 0.5 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.5 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.5 |